(Q37785841)

23 August 2017

title

Should all hypertensive dialysis patients receive a blocker of the Renin-Angiotensin system? (English)

1 reference

23 August 2017

Should All Hypertensive Dialysis Patients Receive a Blocker of the Renin-Angiotensin System? (English)

1 reference

https://api.crossref.org/works/10.1007/S11906-010-0137-Z

7 July 2024

0 references

Rajiv Agarwal

2

1 reference

23 August 2017

Arjun D. Sinha

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20821077

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20821077

7 July 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

http://www.current-reports.com/1522-6417/12/356

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20821077

http://link.springer.com/content/pdf/10.1007/s11906-010-0137-z.pdf

7 July 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11906-010-0137-Z

http://link.springer.com/article/10.1007/s11906-010-0137-z/fulltext.html

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11906-010-0137-Z

http://link.springer.com/content/pdf/10.1007/s11906-010-0137-z

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11906-010-0137-Z

Current Hypertension Reports

7 July 2024

published in

1 reference

23 August 2017

volume

12

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

356-363

1 reference

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0137-Z

Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0137-Z

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0137-Z

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-010-0137-Z

How to preserve residual renal function in patients with chronic kidney disease and on dialysis?

21 January 2018

1 reference

12 December 2020

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

1 reference

12 December 2020

Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients

1 reference

12 December 2020

Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients

1 reference

12 December 2020

Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

1 reference

12 December 2020

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials

1 reference

12 December 2020

Angiotensin II receptor antagonists supplementation is associated with arterial stiffness: insight from a retrospective study in 116 peritoneal dialysis patients

1 reference

12 December 2020

Evaluation of the Losartan in Hemodialysis (ELHE) Study

1 reference

12 December 2020

Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial

1 reference

12 December 2020

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

12 December 2020

Heart failure as a cause for hospitalization in chronic dialysis patients

1 reference

12 December 2020

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction.

1 reference

12 December 2020

Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.

1 reference

12 December 2020

FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics

1 reference

12 December 2020

Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors

1 reference

12 December 2020

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

12 December 2020

Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis

1 reference

12 December 2020

Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis--a randomized study.

1 reference

12 December 2020

Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?

1 reference

12 December 2020

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

12 December 2020

A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness.

1 reference

12 December 2020

Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis

1 reference

12 December 2020

Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study

1 reference

12 December 2020

Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients

1 reference

12 December 2020

Incident acute coronary syndromes in chronic dialysis patients in the United States

1 reference

12 December 2020

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials.

1 reference

12 December 2020

Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis

1 reference

12 December 2020

Spironolactone in chronic hemodialysis patients improves cardiac function.

1 reference

12 December 2020

No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

12 December 2020

Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial

1 reference

12 December 2020

ACE inhibitors and survival of hemodialysis patients

1 reference

12 December 2020

Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses

1 reference

12 December 2020

Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis

1 reference

12 December 2020

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States

1 reference

12 December 2020

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients

1 reference

12 December 2020

Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy

1 reference

12 December 2020

Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects.

1 reference

12 December 2020

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

12 December 2020

Hypertension in renal parenchymal disease: why is it so resistant to treatment?

1 reference

12 December 2020

Calcium channel blocker use and mortality among patients with end-stage renal disease

1 reference

12 December 2020

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

1 reference

12 December 2020

ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients

1 reference

12 December 2020

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

23

19

59

H Suzuki

2003

1 reference

https://api.crossref.org/works/10.1007/S11906-010-0137-Z

7 July 2024

Identifiers

1 reference

23 August 2017

1 reference